GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Global Inc (OTCPK:CBGL) » Definitions » Earnings per Share (Diluted)

CBGL (Cannabis Global) Earnings per Share (Diluted) : $-0.02 (TTM As of May. 2022)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Global Earnings per Share (Diluted)?

Cannabis Global's Earnings per Share (Diluted) for the three months ended in May. 2022 was $-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2022 was $-0.02.

Cannabis Global's EPS (Basic) for the three months ended in May. 2022 was $-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in May. 2022 was $-0.02.

Cannabis Global's EPS without NRI for the three months ended in May. 2022 was $-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in May. 2022 was $-0.02.


Cannabis Global Earnings per Share (Diluted) Historical Data

The historical data trend for Cannabis Global's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Global Earnings per Share (Diluted) Chart

Cannabis Global Annual Data
Trend Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.02 -0.03 -0.29 -0.13

Cannabis Global Quarterly Data
Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.02 - - -

Competitive Comparison of Cannabis Global's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Global's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's PE Ratio distribution charts can be found below:

* The bar in red indicates where Cannabis Global's PE Ratio falls into.



Cannabis Global Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Cannabis Global's Earnings Per Share (Diluted) for the fiscal year that ended in Aug. 2021 is calculated as

Diluted Earnings Per Share (A: Aug. 2021 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-7.835-0)/58.289
=-0.13

Cannabis Global's Earnings Per Share (Diluted) for the quarter that ended in May. 2022 is calculated as

Diluted Earnings Per Share (Q: May. 2022 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-0.475-0)/516.732
=-0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Cannabis Global  (OTCPK:CBGL) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Cannabis Global Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Cannabis Global's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Global Business Description

Traded in Other Exchanges
N/A
Address
520 S Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071
Cannabis Global Inc manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.
Executives
Jim L. Riley director C/O CANNABIS GLOBAL INC., 520 S GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Ghs Investments, Llc 10 percent owner 0830 SOUTH EASTERN AVENUE, #124-376, LAS VEGAS NV 89123
Hymers Iii R. Leslie director, 10 percent owner 520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Arman Tabatabaei director, officer: CEO, CFO 520 SOUTH GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Lauderdale Holdings, Llc director, 10 percent owner, officer: CEO/President/CFO 1919 NW 19 STREET, FT LAUDERDALE FL 33311
Harmel S Rayat 10 percent owner 700 - 688 WEST HASTINGS STREET, VANCOUVER A1 V6B 1P1
David A Gamache director, officer: SECRETARY/TREASURER/CFO 3905 NATIONAL DRIVE, SUITE 110, BURTONSVILLE MD 20866
Meetesh V Patel director, officer: PRESIDENT/CEO 8775 CENTRE PARK DRIVE, # 210, COLUMBIA MD 21045
Pattiann Hiranandani director 3905 NATIONAL DRIVE, BURTONSVILLE MD 20866

Cannabis Global Headlines

From GuruFocus